Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NOD2/CARD15: relevance in clinical practice.

Severine Vermeire1

  • 1Gastroenterology Unit, University hospital Gasthuisberg Leuven, Herestraat 49, 3000 Leuven, Belgium. severine.vermeire@uz.kuleuven.ac.be

Best Practice & Research. Clinical Gastroenterology
|May 26, 2004
PubMed
Summary

NOD2/CARD15 genotyping in Crohn's disease primarily links to small-bowel issues. Further research is needed to confirm if these mutations predict disease severity or guide treatment strategies effectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thiopurines in Pediatric Inflammatory Bowel Disease: Current and Future Place.

Paediatric drugs·2020
Same author

JAK Inhibitors: Back to Small Molecules for the Treatment of IBD.

Journal of Crohn's & colitis·2020
Same author

Molecular Changes in the Non-Inflamed Terminal Ileum of Patients with Ulcerative Colitis.

Cells·2020
Same author

2020 international consensus on ANCA testing beyond systemic vasculitis.

Autoimmunity reviews·2020
Same author

Long-term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort.

United European gastroenterology journal·2020
Same author

Fibrogenesis in chronic murine colitis is independent of innate lymphoid cells.

Immunity, inflammation and disease·2020

Area of Science:

  • Genetics
  • Gastroenterology
  • Immunology

Background:

  • The NOD2/CARD15 gene is implicated in Crohn's disease (CD) pathogenesis.
  • Previous studies suggest a link between NOD2/CARD15 mutations and specific CD phenotypes.

Purpose of the Study:

  • To evaluate the current clinical utility of NOD2/CARD15 genotyping in Crohn's disease.
  • To explore the association of NOD2/CARD15 variants with disease behavior, treatment response, and diagnostic challenges.

Main Methods:

  • Review of existing scientific literature on NOD2/CARD15 mutations in Crohn's disease.
  • Analysis of data regarding genotype-phenotype correlations and treatment outcomes.

Main Results:

  • NOD2/CARD15 mutations are consistently associated with small-bowel involvement in Crohn's disease.
  • The predictive value of these mutations for fibrostenotic disease behavior requires further investigation.
  • Current evidence does not support NOD2/CARD15 genotyping for differentiating indeterminate colitis or predicting response to anti-TNF therapies.

Conclusions:

  • The clinical relevance of NOD2/CARD15 genotyping in Crohn's disease remains limited.
  • Further studies are necessary to determine if NOD2/CARD15 variants can guide more aggressive treatment strategies.
  • Screening of asymptomatic relatives is not currently recommended due to a lack of preventive interventions.

Related Experiment Videos